A pilot randomised, open, uncontrolled, clinical study of two dosages of St John's Wort (Hypericum perforatum) herb extract (LI-160) as an aid to motivational/behavioural support in smoking cessation

Planta Medica

Volumn 72, Issue 4, 2006, Pages 378-382

  Barnes, Joanne ^a,c   Barber, Nick ^a   Wheatley, David ^b   Williamson, Elizabeth M ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b University of Auckland ^*

^c UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

HERBACEOUS AGENT; HYPERICUM PERFORATUM EXTRACT;

ADULT; ANXIETY DISORDER; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMMON COLD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRY SKIN; DYSPNEA; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; HYPERICUM PERFORATUM; INSOMNIA; MALE; MEDICINAL PLANT; MOUTH ULCER; NEPHROLITHIASIS; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; SMOKING CESSATION; STOMACH PAIN;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS; BEHAVIOR THERAPY; FEMALE; HUMANS; HYPERICUM; MALE; MIDDLE AGED; PHYTOTHERAPY; PILOT PROJECTS; PLANT EXTRACTS; PROSPECTIVE STUDIES; SMOKING CESSATION; TREATMENT OUTCOME;

HYPERICUM PERFORATUM;

EID: 33645505628     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-916219     Document Type: Article

References (15)

1. Linde K, Mulrow CD, Berner M, Egger M. St John's wort for depression. The Cochrane Database of Systematic Reviews. 2005: Issue 3: Art. No. CD000448. DOI: 10.1002/14651858.CD000448.pub2
2. Barnes J, Anderson LA, Phillipson JD. St John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties. J Pharm Pharmacol 2001; 53: 583-600
3. Butterweck V. Mechanism of action of St John's wort in depression: what is known? CNS Drugs 2003; 17: 539-62
4. Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation. The Cochrane Database of Systematic Reviews. 2004: Issue 4: Art. No. CD000031. DOI: 10.1002/14651858.CD000031.pub2
5. Hurt RD, Sachs DPL, Glover ED, Offord KP, Johnston JA, Dale LC et al. A comparison of sustained-release bupropion and placebo for smoking cessation. New Eng J Med 1997; 337: 1195-202
6. Jorenby DE, Leischow SJ, Nides MA, Rennard SI, Johnston JA, Hughes AR et al. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. New Eng J Med 1999; 340: 685-91
7. Anon. Zyban [bupropion (amfebutamone)] - safety reminder. Curr Probl Pharmacovigilance 2001; 27: 5
8. Ernst E, Rand JI, Barnes J, Stevinson C. Adverse effects profile of the herbal antidepressant St John's wort (Hypericum perforatum L). Eur J Clin Pharmacol 1998; 54: 589-94
9. Silagy C, Lancaster T, Stead L, Mant D, Fowler G. Nicotine replacement therapy for smoking cessation. The Cochrane Database of Systematic Reviews. 2004: Issue 3: Art. No. CD000146. DOI: 10.1002/14651858. CD000146.pub2
10. Lancaster T, Stead LF. Individual behavioural counselling for smoking cessation. The Cochrane Database of Systematic Reviews. 2002: Issue 3: Art. No. CD001292. DOI: 10.1002/14651858.CD001292
11. Coleman T. ABC of smoking cessation. Special groups of smokers. BMJ 2004; 328: 575-7
12. Prochazka AV, Weaver MJ, Keller RT, Fryer GE, Licari PA, Lofaso DA. A randomized trial of nortriptyline for smoking cessation. Arch Intern Med 1998; 158: 2035-9
13. Catania MA, Firenzuoli F, Crupi A, Mannucci C, Caputi AP, Calapai G. Hypericum perforatum attenuates nicotine withdrawal signs in mice. Psychopharmacology 2003; 169: 186-9
14. Lee HJ, Lee JH. Effects of medicinal herb tea on the smoking cessation and reducing smoking withdrawal symptoms. Am J Chin Med 2005; 33: 127-38
15. Prochaska JO, DiClemente CC. Stages and processes of self-change of smoking: toward an integrative model of change. J Consult Clin Psychol 1983; 51: 390-5